Cargando…

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection

The clinical utility of the splenic arterial pulsatility index (SAPI), a duplex Doppler ultrasonographic index, to predict the stage of hepatic fibrosis in hemodialysis patients with chronic hepatitis C virus (HCV) infection remains elusive. We conducted a retrospective, cross-sectional study to inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chen-Hua, Fang, Yu-Jen, Liu, Chun-Jen, Su, Tung-Hung, Huang, Shang-Chin, Tseng, Tai-Chung, Wu, Jo-Hsuan, Chen, Pei-Jer, Kao, Jia-Horng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004191/ https://www.ncbi.nlm.nih.gov/pubmed/36902807 http://dx.doi.org/10.3390/jcm12052020

Ejemplares similares

Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
por: Liu, Chen-Hua, et al.
Publicado: (2020)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
por: Wu, Jer-Wei, et al.
Publicado: (2021)

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Direct comparison of biopsy techniques for hepatic malignancies
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Elimination of Hepatitis B: Is It a Mission Possible?
por: Tseng, Tai-Chung, et al.
Publicado: (2017)

Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
por: Su, Tung-Hung, et al.
Publicado: (2013)

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2017)

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
por: Liu, Chen-Hua, et al.
Publicado: (2018)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
por: Lee, Jia-Jung, et al.
Publicado: (2020)

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments
por: Nien, Hsiao-Ching, et al.
Publicado: (2017)

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
por: Wu, Hui-Lin, et al.
Publicado: (2016)

Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead
por: Liu, Chun-Jen, et al.
Publicado: (2020)

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
por: Su, Tung-Hung, et al.
Publicado: (2017)

Discrepancy between Serological and Virological Analysis of Viral Hepatitis in Hemodialysis Patients
por: Chang, Jer-Ming, et al.
Publicado: (2014)

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
por: Li, Yung-Tsung, et al.
Publicado: (2016)

Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
por: Yeh, Ming-Lun, et al.
Publicado: (2011)

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
por: Tseng, Tai-Chung, et al.
Publicado: (2012)

Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2014)

Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage
por: Cheng, Yi-Wen, et al.
Publicado: (2019)

Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells
por: Kong, Hongyan, et al.
Publicado: (2020)

Vegetarian diet may ameliorate uremic pruritus in hemodialysis patients
por: Tseng, Chun-Yang, et al.
Publicado: (2018)

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
por: Su, Tung-Hung, et al.
Publicado: (2012)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Hong, Chun-Ming, et al.
Publicado: (2021)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
por: Huang, Shang-Chin, et al.
Publicado: (2023)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
por: Lan, Ting-Yuan, et al.
Publicado: (2023)

Examining the associations among intraocular pressure, hepatic steatosis, and anthropometric parameters
por: Chen, Ying-Jen, et al.
Publicado: (2019)

Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
por: Liu, Chun Jen, et al.
Publicado: (2021)

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
por: Liu, Chen-Hua, et al.
Publicado: (2015)

Tuberculosis Presenting as Hepatic and Splenic Microabscesses
por: Gaba, Saurabh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vc9qgbrvr3jq9uqv91r1mcbckt